Photoactivated inhibition of cathepsin K in a 3D tumor model. - Wikidata - awgldk - TriplyDB

Photoactivated inhibition of cathepsin K in a 3D tumor model.

Photoactivated inhibition of cathepsin K in a 3D tumor model.

http://www.wikidata.org/entity/Q38791995

about

Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos.Effects of Methyl Substitution in Ruthenium Tris(2-pyridylmethyl)amine Photocaging Groups for Nitriles.Caging the uncageable: using metal complex release for photochemical control over irreversible inhibition.New 3D-Culture Approaches to Study Interactions of Bone Marrow Adipocytes with Metastatic Prostate Cancer Cells Photochemical and Photobiological Activity of Ru(II) Homoleptic and Heteroleptic Complexes Containing Methylated Bipyridyl-type Ligands.Effects of the Bidentate Ligand on the Photophysical Properties, Cellular Uptake, and (Photo)cytotoxicity of Glycoconjugates Based on the [Ru(tpy)(NN)(L)]2+ Scaffold.Ru(ii) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles.Photodynamic therapy in 3D cancer models and the utilisation of nanodelivery systems.Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.

P2860

Q31143548-812D3589-B668-41F3-B87C-AF4F7109869D Q37138342-46CC5F8B-638F-480D-82E2-E44D603E94B3 Q42380738-9266B89E-5F58-4E74-88F4-5A9D0CE20AE4 Q42431355-5C450059-E1E2-41E8-952D-FA1A1302059B Q46300487-D8DC7C8B-870F-4862-81E9-99A91CA71996 Q48151913-8BB98D8C-A309-4476-883C-A5497A6FF950 Q50091548-E12E0EEC-0A8C-4146-922C-A58A8C76CC60 Q50142281-8B8FB928-CF23-4649-89D6-EEA608444A01 Q55365212-F7601B4E-34CD-4100-8657-94273DB2C23B

P2860

Photoactivated inhibition of cathepsin K in a 3D tumor model.

http://www.wikidata.org/entity/Q38791995

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Photoactivated inhibition of cathepsin K in a 3D tumor model.

@en

type

label

Photoactivated inhibition of cathepsin K in a 3D tumor model.

@en

prefLabel

Photoactivated inhibition of cathepsin K in a 3D tumor model.

@en

P1433

Q38791995-DE77CA95-159D-4B8D-B9C3-65DDD4F28BB9

P1476

Q38791995-B6471F87-4DAD-48A5-8757-3A3E7CBDA825

P2093

Q38791995-170B07BE-9A06-4294-99C6-4BED9C579C69

Q38791995-3AE68991-2C54-42F8-A66B-48953A177296

Q38791995-5F4E0CDC-E767-459F-89AC-E9034EFBBA06

Q38791995-69962956-CBD8-41B3-BBED-5F6C8B1291EF

Q38791995-84F025A2-8896-46EC-AAFC-36074F8E518E

Q38791995-8D51C4D3-55C5-49E5-B84A-07A941D3BAA9

P2860

Q38791995-01C03C51-DDE8-4133-A293-CBA65FE26CE3

Q38791995-04DC5EB3-DB40-450A-A58E-DAFA1F4A5408

Q38791995-07744B77-B712-4444-977F-BC2405DFE3BA

Q38791995-07BFFDB7-4472-4EAD-83F0-1560CBF8AE97

Q38791995-15B43155-C05A-411E-8368-DD64877CA884

Q38791995-1C715997-E9BB-4FE7-80CD-EF332B18F910

Q38791995-1D9811BD-2C5C-4631-AD84-1BF2360514C4

Q38791995-22F4451F-FE7A-490E-9555-5956C3A4BC79

Q38791995-2315902A-66C3-46D9-8CC7-101F094BB0E3

Q38791995-24421E7A-3F66-4028-A709-A63AF113C6D1

P304

Q38791995-00C40AA3-3C5D-4E58-B4E9-662C93B0B91E

P31

Q38791995-64733817-A86C-4276-9BD4-97223C314922

P356

Q38791995-24F44D2B-BD9D-4866-A7B4-838DD6D0049D

P433

Q38791995-6DF3F9D6-37FA-4F66-8B2D-8BC0F30C082E

P478

Q38791995-97154A04-4DCF-46E1-93FF-0E82E11D5C14

P577

Q38791995-AB752DE1-4201-46C1-8FE0-84BD87DC32BD

P698

Q38791995-BCFC6B6A-ABBE-4C95-9398-74F40A49E34F

P921

Q38791995-90124059-E4F9-41A8-9115-FA5FB25298D1

P932

Q38791995-6B6C79D3-B2C2-417C-AB80-31955E51A5D0

P356

P1433

Biological Chemistry

P1476

Photoactivated inhibition of cathepsin K in a 3D tumor model.

@en

P2093

Claudia Turro

http://www.w3.org/2001/XMLSchema#string

Erandi Rajagurubandara

http://www.w3.org/2001/XMLSchema#string

Izabela Podgorski

http://www.w3.org/2001/XMLSchema#string

Jeremy J Kodanko

http://www.w3.org/2001/XMLSchema#string

Mackenzie K Herroon

http://www.w3.org/2001/XMLSchema#string

Rajgopal Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore

Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design

Irreversible inhibitors of serine, cysteine, and threonine proteases

Protease inhibitors: current status and future prospects

Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound

Light activation of a cysteine protease inhibitor: caging of a peptidomimetic nitrile with Ru(II)(bpy)2

Inhibition of cathepsin activity in a cell-based assay by a light-activated ruthenium compound.

Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism.

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.

Optical control of focal epilepsy in vivo with caged γ-aminobutyric acid.

P304

571-582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/HSZ-2015-0274

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

397

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26901495

http://www.w3.org/2001/XMLSchema#string

P921

photoactivation

P932

5901740

http://www.w3.org/2001/XMLSchema#string